In Wednesday’s Wall Street session, Angiodynamic Inc (NASDAQ:ANGO) shares traded at $10.23, up 0.69% from the previous session.
ANGO stock price is now 4.75% away from the 50-day moving average and 13.96% away from the 200-day moving average. The market capitalization of the company currently stands at $415.41M.
With the price target maintained at $12, Oppenheimer recently Upgraded its rating from Perform to Outperform for Angiodynamic Inc (NASDAQ: ANGO). On September 25, 2023, H.C. Wainwright recently initiated its ‘Buy’ rating on the stock quoting a target price of $19, while ‘Raymond James’ rates the stock as ‘Outperform’
In other news, Nighan Warren JR, SVP Quality and Regulatory sold 4,060 shares of the company’s stock on Jan 16 ’25. The stock was sold for $49,979 at an average price of $12.31. Upon completion of the transaction, the SVP Quality and Regulatory now directly owns 41,817 shares in the company, valued at $0.43 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 16 ’25, Officer Nighan Warren JR bought 4,060 shares of the business’s stock. A total of $49,979 was incurred on buying the stock at an average price of $12.31. A total of 4.63% of the company’s stock is owned by insiders.
During the past 12 months, Angiodynamic Inc has had a low of $5.47 and a high of $13.50. As of last week, the company has a debt-to-equity ratio of 0.02, a current ratio of 2.21, and a quick ratio of 1.40.
The net profit margin was -14.61% and return on equity was -20.46% for ANGO. The company reported revenue of $72.0 million for the quarter, compared to $75.18 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -4.23 percent.
